SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-20-017615
Filing Date
2020-07-16
Accepted
2020-07-16 09:27:01
Documents
5
Period of Report
2020-07-16
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea124233-8k_inmunebio.htm 8-K 34708
2 UNDERWRITING AGREEMENT, DATED JULY 16, 2020, BY AND BETWEEN INMUNE BIO, INC. AND ea124233ex1-1_inmune.htm EX-1.1 250135
3 OPINION OF SICHENZIA ROSS FERENCE LLP ea124233ex5-1_inmune.htm EX-5.1 10726
4 PRESS RELEASE DATED JULY 16, 2020 ea124233ex99-1_inmune.htm EX-99.1 10178
5 GRAPHIC ex5-1_001.jpg GRAPHIC 16393
  Complete submission text file 0001213900-20-017615.txt   329642
Mailing Address 1200 PROSPECT STREET SUITE 525 LA JOLLA CA 92037
Business Address 1200 PROSPECT STREET SUITE 525 LA JOLLA CA 92037 8589643720
Inmune Bio, Inc. (Filer) CIK: 0001711754 (see all company filings)

IRS No.: 475205835 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38793 | Film No.: 201030863
SIC: 2836 Biological Products, (No Diagnostic Substances)